What are the side effects and potential adverse effects of kratom use?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Kratom Side Effects

Kratom should be discontinued due to serious adverse effects including opioid-like toxicity, hepatotoxicity, seizures, withdrawal syndrome, and cardiovascular complications, with the FDA explicitly warning against its use. 1

Acute/Short-Term Side Effects

Neurological Effects

  • Opioid-like toxicity: Respiratory depression, sedation, altered mental state, loss of consciousness, and lethargy 2, 3
  • Seizures: Particularly with chronic use 1, 4
  • CNS stimulation or depression depending on dose 5, 4
  • Confusion, dizziness, and delirium 6

Cardiovascular Effects

  • Tachycardia and arrhythmias 2, 6
  • Hypertension or hypotension 4
  • Risk of coronary vasospasm 6

Gastrointestinal Effects

  • Nausea and vomiting 6
  • Constipation (opioid-like effect) 4

Other Acute Effects

  • Dry mouth 4
  • Urinary retention 4
  • Visual disturbances 4

Serious/Life-Threatening Complications

Hepatotoxicity

Kratom causes cholestatic liver injury that can progress to liver transplantation in severe cases 7. The pattern is predominantly cholestatic, presenting with:

  • Jaundice
  • Elevated liver enzymes (transaminases and bilirubin)
  • In 4 documented cases, progression to liver transplantation was required 7
  • Most cases improve with kratom cessation, but monitoring is essential 7

Respiratory Depression

  • Variable response to naloxone - some cases respond, others do not 3
  • Risk of delayed or recurrent respiratory depression even after initial naloxone response 3
  • Extended observation periods are necessary following reversal attempts 3

Withdrawal Syndrome

Kratom must be tapered, not abruptly stopped, particularly when using >5-15 g per day 1. Withdrawal symptoms include:

  • Irritability and restlessness
  • Anxiety
  • Sleep disturbances
  • Appetite changes
  • Abdominal pain
  • Muscle aches
  • Symptoms typically occur within 3 days of cessation and last up to 14 days 8

Long-Term/Chronic Use Effects

Addiction Potential

  • Opioid agonist properties lead to tolerance and physical dependence 1
  • Risk of developing kratom use disorder with chronic use 5, 4
  • Addictive potential similar to opioids 4

Neurological

  • Chronic neurologic effects including seizure risk 1
  • Cognitive impairment with prolonged use 4

Psychiatric

  • Mood disorders
  • Anxiety exacerbation
  • Potential for psychosis at high doses 6

Critical Drug Interactions

Cytochrome P450 Interactions

Kratom inhibits CYP3A4 and CYP2D6 4, 6, creating potential interactions with:

  • Warfarin (very high risk) 8
  • Buprenorphine (high risk) 8
  • Tacrolimus (high risk) 8
  • Chemotherapeutic agents metabolized by these enzymes 8

Serotonergic Medications

Risk of serotonin syndrome when combined with:

  • SSRIs/SNRIs
  • Tramadol
  • Meperidine
  • Other serotonergic agents 6

CNS Depressants

Additive sedation and respiratory depression with:

  • Benzodiazepines
  • Opioids
  • Alcohol
  • Other sedatives 6, 3

Perioperative Considerations

Kratom should be discontinued before surgery 1:

  • Ideally held for 2 weeks preoperatively
  • Must be tapered (not abruptly stopped) due to withdrawal risk 1
  • Opioid-like properties complicate anesthetic management 1
  • May increase anesthetic requirements 1
  • Risk of withdrawal during perioperative period if not properly managed

Special Populations at Risk

Polysubstance Users

  • Most kratom-associated fatalities involve polysubstance use 2, 6
  • Confounding substances complicate attribution of adverse effects 2
  • Enhanced toxicity when combined with other substances 6, 3

Pregnant Women

  • Risk of neonatal abstinence syndrome in exposed neonates 6
  • Insufficient safety data for pregnancy 6

Patients with Liver Disease

  • Baseline liver disease increases risk of hepatotoxicity 7
  • Only 9% of reported liver injury cases had pre-existing liver disease, indicating risk even in healthy individuals 7

Critical Clinical Pitfalls

  1. Kratom is not detected on standard toxicology screens - must specifically request mitragynine testing 6
  2. Product variability is extreme - alkaloid content varies widely between products, making dose-effect relationships unpredictable 5, 4
  3. Naloxone response is inconsistent - do not assume naloxone will reverse toxicity 3
  4. Extended monitoring required - even after apparent reversal, delayed respiratory depression can occur 3
  5. Abrupt cessation causes withdrawal - always taper 1

FDA Position

The FDA explicitly warns against kratom use and seeks to make 7-hydroxymitragynine (a key kratom alkaloid) a controlled substance 1, 9. The Society for Perioperative Assessment and Quality Improvement (SPAQI) does not recommend use of kratom due to potential for serious adverse effects 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.